#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thymic carcinoma Antiphospholipid syndrome Red blood cell abnormality Oesophageal adenocarcinoma stage II Cystic fibrosis lung Oropharyngeal squamous cell carcinoma Adenovirus infection Mantle cell lymphoma recurrent Brain abscess Hyperoxaluria Myelodysplastic syndrome Neurodermatitis Scleroderma associated digital ulcer Follicular lymphoma stage III Gastroenteropancreatic neuroendocrine tumour disease More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Treatment MELAS syndrome – Trials in Disease Epidermolysis bullosa – Life with Disease Osteosarcoma – Trials in Disease Mucopolysaccharidosis II – Treatment Krabbe’s disease – Life with Disease Carcinoid syndrome – Treatment Biotinidase deficiency – Treatment Fragile X syndrome – Basic Information VEXAS syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Treosulfan Davutamig A24110He Tacrolimus Piromelatine METAMIZOLE SODIUM CAL101 Ecopipam Hydrochloride Aminohippuric Acid Betaxolol Elritercept Cenobamate Lisdexamfetamine Dimesylate BENZYLPENICILLIN POTASSIUM Oxybuprocaine Hydrocortisone Ph. Eur. Human Von Willebrand Factor OXYBUTYNIN HYDROCHLORIDE Istradefylline Zenocutuzumab More therapies…

    Learn about Your Condition

    Migraine Aortic disorder Fatty acid oxidation disorder Anal cancer stage III Oxygen saturation Obstructive pancreatitis Mantle cell lymphoma stage IV Pulmonary hypertension Pancreatic fistula Partial seizures Post-acute COVID-19 syndrome Hereditary ataxia Pleomorphic leiomyosarcoma Bone hypertrophy Juvenile absence epilepsy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pulmonary hypertension

  • A study to evaluate the effectiveness of levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction.

    Recruiting

    3 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Levosimendan
    Austria Bulgaria Czechia France Germany Hungary +3

  • A study to evaluate the safety and effectiveness of inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease

    Recruiting

    3 1
    Investigated Diseases:
    • Pulmonary hypertension
    • Interstitial lung disease
    Investigated Drugs:
    • Treprostinil
    Austria Belgium Czechia France Germany Italy +4

  • A Study of Ferric Carboxymaltose to Improve Exercise Ability in Patients with Pulmonary Hypertension and Iron Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary hypertension
    • Iron deficiency
    Investigated Drugs:
    • Ferric Carboxymaltose
    • Sodium Chloride
    Belgium

  • Testing Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Treprostinil Palmitil
    Austria Belgium Czechia Denmark France Germany +6

  • Testing the safety of stopping riociguat in patients with chronic thromboembolic pulmonary hypertension after successful balloon pulmonary angioplasty treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Riociguat
    The Netherlands

  • Long-term Safety Study of Tadalafil and Macitentan for Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Macitentan
    • Selexipag
    • Tadalafil
    Bulgaria Hungary Poland
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!